Provider: BehaviorLive — via AVBCC
Take This Course →Including ethics, supervision, and topics like this one. New live CEU every Wednesday.
Join Free →One of the most difficult transitions for persons affected by cancer is the evolution from a cancer patient in acute treatment to a cancer survivor, either after treatment or on maintenance. The change from a focus on cancer care to whole body care brings a new set of uncertainties. There are uncertainties on the provider side as well: does the oncologist continue to manage care or does the patient transition to primary care or some hybrid of both? In an environment with limited provider availability, do we need alternative solutions to meeting these needs of this fastest growing segment of cancer patients...survivors.
| Certification Body | Credits | Type |
|---|---|---|
| BACB | 1 | General |
John Hennessy is a Associate Principal, Consulting for Payer Sciences John has worked in healthcare delivery for more than 30 years in community and academic settings, as well as in physician’s office and hospital service lines. John’s work at Payer Sciences focuses on how payers, providers, and pay-viders behave and impact access to medicines they need.John was the Executive Director of the Kansas City Cancer Centers, a US Oncology affiliate, which was one of the first oncology practices in the nation to adopt clinical pathways.. In addition, he was Vice President of Operations for Sarah Cannon, the oncology service line for HCA, helping hospitals develop and manage hematology and cancer service lines. He also served as the Executive Director of Community Cancer Programs for the University of Kansas Health System. He is a long-time ASCO member, having served on the Clinical Practice Committee, Practice Guidelines Implementation Network, and the State Affiliates Council; John serves as an editor on the ASCO Edge educational project. John has been a consultant with ASCO’s Practice Support group to review oncology practices for patient-focused and value-based care readiness. John also served on the Board of Trustees for the Association of Community Cancer Centers and was President of the Assembly of Oncology and Hematology Administrators for the Medical Group Management Association. John has experience working on Takeda’s oncology and immunology projects and the H2A programJohn is also the Vice President of the Board of Directors of the Young Survival Coalition, and is a Board Certified Patient Advocate (BCPA). John received a MBA from Duke University and a BA in English from Colorado College.
Dig into the research behind this topic — plain-English summaries written for BCBAs.
279 research articles with practitioner takeaways
252 research articles with practitioner takeaways
225 research articles with practitioner takeaways
You earn CEUs from a dozen different places. Upload any certificate — from here, your employer, conferences, wherever — and always know exactly where you stand. Learning, Ethics, Supervision, all handled.
No credit card required. Cancel anytime.
All behavior-analytic intervention is individualized. The information on this page is for educational purposes and does not constitute clinical advice. Treatment decisions should be informed by the best available published research, individualized assessment, and obtained with the informed consent of the client or their legal guardian. Behavior analysts are responsible for practicing within the boundaries of their competence and adhering to the BACB Ethics Code for Behavior Analysts.